ABC
HRTX icon

Associated Banc-Corp’s Heron Therapeutics HRTX Stock Holding History

Associated Banc-Corp’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-69
Closed -$1K – 556
2020
Q4 		$1K Hold
69
– – ﹤0.01% 920
2020
Q3 		$1K Buy
+69
New +$1.08K ﹤0.01% 880

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Associated Banc-Corp's HRTX Position: Q1 2021 in Review

Associated Banc-Corp sold out of Heron Therapeutics (HRTX) in Q1 2021, closing a stake of 69 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in HRTX in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 193 funds tracked by Wall St. Rank hold HRTX as of Q1 2021.

  • Associated Banc-Corp reported no remaining Heron Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 69 Heron Therapeutics shares in Q1 2021, an estimated $1K.
  • Associated Banc-Corp first reported a position in Heron Therapeutics in Q3 2020 and held it in 2 quarters.
  • Associated Banc-Corp's Heron Therapeutics position peaked at $1K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.